Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Reduced memory skills and increased hair cortisol levels in recent Ecstasy/MDMA users: significant but independent neurocognitive and neurohormonal deficits.

Downey LA, Sands H, Jones L, Clow A, Evans P, Stalder T, Parrott AC.

Hum Psychopharmacol. 2015 May;30(3):199-207. doi: 10.1002/hup.2474.

PMID:
25900184
2.

Increased cortisol levels in hair of recent Ecstasy/MDMA users.

Parrott AC, Sands HR, Jones L, Clow A, Evans P, Downey LA, Stalder T.

Eur Neuropsychopharmacol. 2014 Mar;24(3):369-74. doi: 10.1016/j.euroneuro.2013.11.006. Epub 2013 Nov 26.

PMID:
24333019
3.

All cancers age-adjusted mortality rate surpasses diseases of the heart.

Wyatt SW, Sands HR, Maynard WR, Humbaugh KE.

J Cancer. 2012;3:113-6. doi: 10.7150/jca.4111. Epub 2012 Mar 3. No abstract available.

4.

Graft-versus-host disease: a complex long-term side effect of hematopoietic stem cell transplant.

Barton-Burke M, Dwinell DM, Kafkas L, Lavalley C, Sands H, Proctor C, Johnson E.

Oncology (Williston Park). 2008 Oct;22(11 Suppl Nurse Ed):31-45. Review.

PMID:
19856578
5.

Tuberculosis knowledge, perceived risk and risk behaviors among homeless adults: effect of ethnicity and injection drug use.

Nyamathi A, Sands H, Pattatucci-Aragón A, Berg J, Leake B.

J Community Health. 2004 Dec;29(6):483-97.

6.

Perception of health status by homeless US veterans.

Nyamathi A, Sands H, Pattatucci-Aragón A, Berg J, Leake B, Hahn JE, Morisky D.

Fam Community Health. 2004 Jan-Mar;27(1):65-74.

PMID:
14724503
7.

Development of a bioanalytical liquid chromatography method for quantitation of 9-nitrocamptothecin in human plasma.

Gounder MK, Sun SL, Sands H, Lin Y, Shih WJ, Gu Z, Charles-Williams S, Roychowdhury M, Rajendra R, Rubin EH.

J Chromatogr B Analyt Technol Biomed Life Sci. 2004 Jan 5;799(1):63-72.

PMID:
14659436
8.

Ebola virus: immune mechanisms of protection and vaccine development.

Nyamathi AM, Fahey JL, Sands H, Casillas AM.

Biol Res Nurs. 2003 Apr;4(4):276-81. Review.

PMID:
12698920
9.

A current review of Ebola virus: pathogenesis, clinical presentation, and diagnostic assessment.

Casillas AM, Nyamathi AM, Sosa A, Wilder CL, Sands H.

Biol Res Nurs. 2003 Apr;4(4):268-75. Review.

PMID:
12698919
10.

Preclinical activity of an i.v. formulation of rubitecan in IDD-P against human solid tumor xenografts.

Sands H, Mishra A, Stoeckler JD, Hollister B, Chen SF.

Anticancer Drugs. 2002 Oct;13(9):965-75.

PMID:
12394260
11.

Raman spectroscopy and imaging of beta-carotene in live corpus luteum cells.

Arikan S, Sands HS, Rodway RG, Batchelder DN.

Anim Reprod Sci. 2002 Jun 17;71(3-4):249-66.

PMID:
12047933
12.

Phase I clinical trial of 5-fluoro-pyrimidinone (5FP), an oral prodrug of 5-fluorouracil (5FU).

LoRusso PM, Prakash S, Wozniak A, Flaherty L, Zalupski M, Shields A, Sands H, Parchment R, Jasti B.

Invest New Drugs. 2002 Feb;20(1):63-71.

13.

LEX032, a novel recombinant serpin, protects the brain after transient focal ischemia.

Weaver M, Leshley K, Sands H, Gritman KR, Legos JJ, Tuma RF.

Microvasc Res. 2002 May;63(3):327-34.

PMID:
11969309
14.

9-Nitrocamptothecin is an effective drug for the treatment of human lung tumors: comparison of in vitro and in vivo studies.

Han Z, Wyche JH, Sands H, Pantazis P.

Anticancer Res. 2001 May-Jun;21(3B):1823-7.

PMID:
11497265
15.

LEX 032: a novel recombinant human protein for the treatment of ischaemic reperfusion injury.

Sands H, Tuma RF.

Expert Opin Investig Drugs. 1999 Nov;8(11):1907-1916.

PMID:
11139833
16.
18.

Intrathecal busulfan treatment of human neoplastic meningitis in athymic nude rats.

Archer GE, Sampson JH, McLendon RE, Friedman AH, Colvin OM, Rose M, Sands H, McCullough W, Fuchs HE, Bigner DD, Friedman HS.

J Neurooncol. 1999;44(3):233-41.

PMID:
10720203
20.

Biodistribution and pharmacokinetics of 131I-labeled LEX 032, a recombinant hybrid of antichymotrypsin.

Sands H, Li J, Duggaraju R, Kolan HR, Donegan M, Elove GA, Thakur ML.

Drug Metab Dispos. 1997 May;25(5):631-6.

PMID:
9152604
21.

Inhibition of human leukocyte proteinase 3 by a novel recombinant serine proteinase inhibitor (LEX032).

Groutas WC, Ruan S, Kuang R, Hook JB, Sands H.

Biochem Biophys Res Commun. 1997 Apr 28;233(3):697-9.

PMID:
9168917
22.

Pharmacology and pharmacokinetics of LEX 032, a bioengineered serpin: the first of a potential new class of drugs.

Sands H, Hook JB.

Drug Metab Rev. 1997 Feb-May;29(1-2):309-28. Review. No abstract available.

PMID:
9187523
23.

Biodistribution and metabolism of internally 3H-labeled oligonucleotides. II. 3',5'-blocked oligonucleotides.

Sands H, Gorey-Feret LJ, Ho SP, Bao Y, Cocuzza AJ, Chidester D, Hobbs FW.

Mol Pharmacol. 1995 Mar;47(3):636-46.

PMID:
7700261
24.

Biodistribution and metabolism of internally 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and a phosphorothioate.

Sands H, Gorey-Feret LJ, Cocuzza AJ, Hobbs FW, Chidester D, Trainor GL.

Mol Pharmacol. 1994 May;45(5):932-43.

PMID:
8190109
25.

Radiolabeled monoclonal antibodies for cancer therapy and diagnosis: is it really a chimera?

Sands H.

J Nucl Med. 1992 Jan;33(1):29-32. No abstract available.

26.

Tissue localization of methotrexate-monoclonal-IgM immunoconjugates: anti-SSEA-1 and MOPC 104E in mouse teratocarcinomas and normal tissues.

Ballou B, Jaffe R, Persiani S, Shen WC, Langone JJ, Sands H, Reilandu JM, Curley J, Hakala TR.

Cancer Immunol Immunother. 1992;35(4):251-6.

PMID:
1355010
27.

Experimental studies of radioimmunodetection of cancer: an overview.

Sands H.

Cancer Res. 1990 Feb 1;50(3 Suppl):809s-813s. Review.

28.

Intraperitoneal immunoconjugates.

Griffin TW, Collins J, Bokhari F, Stochl M, Brill AB, Ito T, Emond G, Sands H.

Cancer Res. 1990 Feb 1;50(3 Suppl):1031s-1038s.

29.

Uptake and metabolism of 111In-labeled monoclonal antibody B6.2 by the rat liver.

Jones PL, Brown BA, Sands H.

Cancer Res. 1990 Feb 1;50(3 Suppl):852s-856s.

30.

Pharmacokinetics of 99mTc-metallothionein-B72.3 and its F(ab')2 fragment.

Brown BA, Dearborn CB, Drozynski CA, Sands H.

Cancer Res. 1990 Feb 1;50(3 Suppl):835s-839s.

31.

Physiology of monoclonal antibody accretion by tumors.

Sands H, Jones PL.

Cancer Treat Res. 1990;51:97-122. Review.

PMID:
1977461
32.

Preclinical models and methods for the study of radiolabeled monoclonal antibodies in cancer diagnosis and therapy.

Shah SA, Sands H.

Cancer Treat Res. 1990;51:53-96. Review. No abstract available.

PMID:
1977460
33.

On the accumulation in liver of 111In following administration of the B72.3 antibody.

Hnatowich DJ, Sands H.

J Nucl Med. 1989 Sep;30(9):1575-6. No abstract available.

34.

Biodistribution and pharmacokinetics of recombinant, human 125I-interleukin-2 in mice.

Sands H, Loveless SE.

Int J Immunopharmacol. 1989;11(4):411-6.

PMID:
2789199
35.

Correlation of vascular permeability and blood flow with monoclonal antibody uptake by human Clouser and renal cell xenografts.

Sands H, Jones PL, Shah SA, Palme D, Vessella RL, Gallagher BM.

Cancer Res. 1988 Jan 1;48(1):188-93.

36.

Characterization of in vivo chemistry of cations in the heart.

Mousa SA, Williams SJ, Sands H.

J Nucl Med. 1987 Aug;28(8):1351-7. Review.

37.

Tumor-specific genetically engineered murine/human chimeric monoclonal antibody.

Brown BA, Davis GL, Saltzgaber-Muller J, Simon P, Ho MK, Shaw PS, Stone BA, Sands H, Moore GP.

Cancer Res. 1987 Jul 1;47(13):3577-83.

38.
39.
40.

Pharmacokinetics of the monoclonal antibody B72.3 and its fragments labeled with either 125I or 111In.

Brown BA, Comeau RD, Jones PL, Liberatore FA, Neacy WP, Sands H, Gallagher BM.

Cancer Res. 1987 Feb 15;47(4):1149-54.

42.

Site-related differences in the localization of the monoclonal antibody OX7 in SL2 and SL1 lymphomas.

Sands H, Jones PL, Neacy WP, Shah SA, Gallagher BM.

Cancer Immunol Immunother. 1986;22(3):169-75.

PMID:
3731201
43.

Autoradiographic analysis of monoclonal antibody distribution in human colon and breast tumor xenografts.

Jones PL, Gallagher BM, Sands H.

Cancer Immunol Immunother. 1986;22(2):139-43.

PMID:
3719593
44.
45.

Transport of 42K+, 201Tl+ and [99mTc(dmpe)2.Cl2]+ by neonatal rat myocyte cultures.

Delano ML, Sands H, Gallagher BM.

Biochem Pharmacol. 1985 Sep 15;34(18):3377-80. No abstract available.

PMID:
4038345
46.

Vascular volume and permeability of human and murine tumors grown in athymic mice.

Sands H, Shah SA, Gallagher BM.

Cancer Lett. 1985 May;27(1):15-21.

PMID:
4005823
47.

Comparison of the transport of 42K+, 22Na+, 201Tl+, and [99mTc(dmpe)2 X Cl2]+ using human erythrocytes.

Sands H, Delano ML, Camin LL, Gallagher BM.

Biochim Biophys Acta. 1985 Feb 14;812(3):665-70.

PMID:
3970901
48.

The imaging of small experimental murine tumors grown in the subrenal capsule using monoclonal antibodies.

Sands H, Jones PL, Neacy W, Shah SA, Gallagher BM.

Cancer Lett. 1984 Aug;24(1):65-72.

PMID:
6498801
50.

Editorial comments: cyclic nucleotides and the pathophysiology of the cardiovascular system.

Sands H.

Adv Cyclic Nucleotide Res. 1980;12:93-5. No abstract available.

PMID:
6250377

Supplemental Content

Support Center